#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=The present invention relates to the art of in vivo bone treatment.
1-1	0-3	The	_	_	
1-2	4-11	present	_	_	
1-3	12-21	invention	_	_	
1-4	22-29	relates	_	_	
1-5	30-32	to	_	_	
1-6	33-36	the	_	_	
1-7	37-40	art	_	_	
1-8	41-43	of	_	_	
1-9	44-46	in	_	_	
1-10	47-51	vivo	_	_	
1-11	52-56	bone	_	_	
1-12	57-66	treatment	_	_	
1-13	66-67	.	_	_	

#Text=It finds particular application to in vivo bone transport and lengthening and will be described with particular reference thereto.
2-1	68-70	It	_	_	
2-2	71-76	finds	_	_	
2-3	77-87	particular	_	_	
2-4	88-99	application	_	_	
2-5	100-102	to	_	_	
2-6	103-105	in	_	_	
2-7	106-110	vivo	_	_	
2-8	111-115	bone	_	_	
2-9	116-125	transport	_	_	
2-10	126-129	and	_	_	
2-11	130-141	lengthening	_	_	
2-12	142-145	and	_	_	
2-13	146-150	will	_	_	
2-14	151-153	be	_	_	
2-15	154-163	described	_	_	
2-16	164-168	with	_	_	
2-17	169-179	particular	_	_	
2-18	180-189	reference	_	_	
2-19	190-197	thereto	_	_	
2-20	197-198	.	_	_	

#Text=Intercalary defects in long bones may occur as a result of trauma, resection necessitated by tumors or infection, or acute limb lengthening.
3-1	199-210	Intercalary	_	_	
3-2	211-218	defects	_	_	
3-3	219-221	in	_	_	
3-4	222-226	long	_	_	
3-5	227-232	bones	_	_	
3-6	233-236	may	_	_	
3-7	237-242	occur	_	_	
3-8	243-245	as	_	_	
3-9	246-247	a	_	_	
3-10	248-254	result	_	_	
3-11	255-257	of	_	_	
3-12	258-264	trauma	_	_	
3-13	264-265	,	_	_	
3-14	266-275	resection	_	_	
3-15	276-288	necessitated	_	_	
3-16	289-291	by	_	_	
3-17	292-298	tumors	_	_	
3-18	299-301	or	_	_	
3-19	302-311	infection	_	_	
3-20	311-312	,	_	_	
3-21	313-315	or	_	_	
3-22	316-321	acute	_	_	
3-23	322-326	limb	_	_	
3-24	327-338	lengthening	_	_	
3-25	338-339	.	_	_	

#Text=With appropriate mechanical fixation, these defects may be managed by autogenous bone grafting, segmental allograft reconstruction, or reconstruction using endoprostheses.
4-1	340-344	With	_	_	
4-2	345-356	appropriate	_	_	
4-3	357-367	mechanical	_	_	
4-4	368-376	fixation	_	_	
4-5	376-377	,	_	_	
4-6	378-383	these	_	_	
4-7	384-391	defects	_	_	
4-8	392-395	may	_	_	
4-9	396-398	be	_	_	
4-10	399-406	managed	_	_	
4-11	407-409	by	_	_	
4-12	410-420	autogenous	_	_	
4-13	421-425	bone	_	_	
4-14	426-434	grafting	_	_	
4-15	434-435	,	_	_	
4-16	436-445	segmental	_	_	
4-17	446-455	allograft	_	_	
4-18	456-470	reconstruction	_	_	
4-19	470-471	,	_	_	
4-20	472-474	or	_	_	
4-21	475-489	reconstruction	_	_	
4-22	490-495	using	_	_	
4-23	496-510	endoprostheses	_	_	
4-24	510-511	.	_	_	

#Text=Autogenous bone grafting has the disadvantage of donor site morbidity including pain, increased blood loss, and surgical scarring.
5-1	512-522	Autogenous	_	_	
5-2	523-527	bone	_	_	
5-3	528-536	grafting	_	_	
5-4	537-540	has	_	_	
5-5	541-544	the	_	_	
5-6	545-557	disadvantage	_	_	
5-7	558-560	of	_	_	
5-8	561-566	donor	_	_	
5-9	567-571	site	_	_	
5-10	572-581	morbidity	_	_	
5-11	582-591	including	_	_	
5-12	592-596	pain	_	_	
5-13	596-597	,	_	_	
5-14	598-607	increased	_	_	
5-15	608-613	blood	_	_	
5-16	614-618	loss	_	_	
5-17	618-619	,	_	_	
5-18	620-623	and	_	_	
5-19	624-632	surgical	_	_	
5-20	633-641	scarring	_	_	
5-21	641-642	.	_	_	

#Text=Furthermore, in the case of large defects it may be difficult or impossible to obtain an optimal volume of autogenous bone.
6-1	643-654	Furthermore	_	_	
6-2	654-655	,	_	_	
6-3	656-658	in	_	_	
6-4	659-662	the	_	_	
6-5	663-667	case	_	_	
6-6	668-670	of	_	_	
6-7	671-676	large	_	_	
6-8	677-684	defects	_	_	
6-9	685-687	it	_	_	
6-10	688-691	may	_	_	
6-11	692-694	be	_	_	
6-12	695-704	difficult	_	_	
6-13	705-707	or	_	_	
6-14	708-718	impossible	_	_	
6-15	719-721	to	_	_	
6-16	722-728	obtain	_	_	
6-17	729-731	an	_	_	
6-18	732-739	optimal	_	_	
6-19	740-746	volume	_	_	
6-20	747-749	of	_	_	
6-21	750-760	autogenous	_	_	
6-22	761-765	bone	_	_	
6-23	765-766	.	_	_	

#Text=While allografting eliminates the problem of adequate quantity, the incidence of complications such as infection, fracture, and non-union is increased.
7-1	767-772	While	_	_	
7-2	773-785	allografting	_	_	
7-3	786-796	eliminates	_	_	
7-4	797-800	the	_	_	
7-5	801-808	problem	_	_	
7-6	809-811	of	_	_	
7-7	812-820	adequate	_	_	
7-8	821-829	quantity	_	_	
7-9	829-830	,	_	_	
7-10	831-834	the	_	_	
7-11	835-844	incidence	_	_	
7-12	845-847	of	_	_	
7-13	848-861	complications	_	_	
7-14	862-866	such	_	_	
7-15	867-869	as	_	_	
7-16	870-879	infection	_	_	
7-17	879-880	,	_	_	
7-18	881-889	fracture	_	_	
7-19	889-890	,	_	_	
7-20	891-894	and	_	_	
7-21	895-904	non-union	_	_	
7-22	905-907	is	_	_	
7-23	908-917	increased	_	_	
7-24	917-918	.	_	_	

#Text=The risk of exposure to HIV or hepatitis is another concern, raised by the use of allogenous material, bone or transfusion blood to treat bleeding.
8-1	919-922	The	_	_	
8-2	923-927	risk	_	_	
8-3	928-930	of	_	_	
8-4	931-939	exposure	_	_	
8-5	940-942	to	_	_	
8-6	943-946	HIV	_	_	
8-7	947-949	or	_	_	
8-8	950-959	hepatitis	_	_	
8-9	960-962	is	_	_	
8-10	963-970	another	_	_	
8-11	971-978	concern	_	_	
8-12	978-979	,	_	_	
8-13	980-986	raised	_	_	
8-14	987-989	by	_	_	
8-15	990-993	the	_	_	
8-16	994-997	use	_	_	
8-17	998-1000	of	_	_	
8-18	1001-1011	allogenous	_	_	
8-19	1012-1020	material	_	_	
8-20	1020-1021	,	_	_	
8-21	1022-1026	bone	_	_	
8-22	1027-1029	or	_	_	
8-23	1030-1041	transfusion	_	_	
8-24	1042-1047	blood	_	_	
8-25	1048-1050	to	_	_	
8-26	1051-1056	treat	_	_	
8-27	1057-1065	bleeding	_	_	
8-28	1065-1066	.	_	_	

#Text=In 1954, Ilizarov reported that mature bone can be elongated by gradual distraction of a fracture callus and called this process distraction osteogenesis.
9-1	1067-1069	In	_	_	
9-2	1070-1074	1954	_	_	
9-3	1074-1075	,	_	_	
9-4	1076-1084	Ilizarov	_	_	
9-5	1085-1093	reported	_	_	
9-6	1094-1098	that	_	_	
9-7	1099-1105	mature	_	_	
9-8	1106-1110	bone	_	_	
9-9	1111-1114	can	_	_	
9-10	1115-1117	be	_	_	
9-11	1118-1127	elongated	_	_	
9-12	1128-1130	by	_	_	
9-13	1131-1138	gradual	_	_	
9-14	1139-1150	distraction	_	_	
9-15	1151-1153	of	_	_	
9-16	1154-1155	a	_	_	
9-17	1156-1164	fracture	_	_	
9-18	1165-1171	callus	_	_	
9-19	1172-1175	and	_	_	
9-20	1176-1182	called	_	_	
9-21	1183-1187	this	*[1]	_	
9-22	1188-1195	process	*[1]	_	
9-23	1196-1207	distraction	*[2]	9-21[1_2]	
9-24	1208-1220	osteogenesis	*[2]	_	
9-25	1220-1221	.	_	_	

#Text=The application of this technique in the form of bone segment transport or gradual bone lengthening can obviate the need for open bone grafting in many large diaphyseal defects.
10-1	1222-1225	The	_	_	
10-2	1226-1237	application	_	_	
10-3	1238-1240	of	_	_	
10-4	1241-1245	this	_	_	
10-5	1246-1255	technique	_	_	
10-6	1256-1258	in	_	_	
10-7	1259-1262	the	_	_	
10-8	1263-1267	form	_	_	
10-9	1268-1270	of	_	_	
10-10	1271-1275	bone	_	_	
10-11	1276-1283	segment	_	_	
10-12	1284-1293	transport	_	_	
10-13	1294-1296	or	_	_	
10-14	1297-1304	gradual	_	_	
10-15	1305-1309	bone	_	_	
10-16	1310-1321	lengthening	_	_	
10-17	1322-1325	can	_	_	
10-18	1326-1333	obviate	_	_	
10-19	1334-1337	the	_	_	
10-20	1338-1342	need	_	_	
10-21	1343-1346	for	_	_	
10-22	1347-1351	open	_	_	
10-23	1352-1356	bone	_	_	
10-24	1357-1365	grafting	_	_	
10-25	1366-1368	in	_	_	
10-26	1369-1373	many	_	_	
10-27	1374-1379	large	_	_	
10-28	1380-1390	diaphyseal	_	_	
10-29	1391-1398	defects	_	_	
10-30	1398-1399	.	_	_	

#Text=Ilizarov used external fixation, with wires passing through the limb and bone, and connected to the external frame.
11-1	1400-1408	Ilizarov	_	_	
11-2	1409-1413	used	_	_	
11-3	1414-1422	external	_	_	
11-4	1423-1431	fixation	_	_	
11-5	1431-1432	,	_	_	
11-6	1433-1437	with	_	_	
11-7	1438-1443	wires	_	_	
11-8	1444-1451	passing	_	_	
11-9	1452-1459	through	_	_	
11-10	1460-1463	the	_	_	
11-11	1464-1468	limb	_	_	
11-12	1469-1472	and	_	_	
11-13	1473-1477	bone	_	_	
11-14	1477-1478	,	_	_	
11-15	1479-1482	and	_	_	
11-16	1483-1492	connected	_	_	
11-17	1493-1495	to	_	_	
11-18	1496-1499	the	_	_	
11-19	1500-1508	external	_	_	
11-20	1509-1514	frame	_	_	
11-21	1514-1515	.	_	_	

#Text=However, transfixing wires used in this technique can cause significant complications including wire site infection, bone infection, pain, scarring, and restricted joint motion due to the transfixation of tendons and muscles.
12-1	1516-1523	However	_	_	
12-2	1523-1524	,	_	_	
12-3	1525-1536	transfixing	_	_	
12-4	1537-1542	wires	_	_	
12-5	1543-1547	used	_	_	
12-6	1548-1550	in	_	_	
12-7	1551-1555	this	_	_	
12-8	1556-1565	technique	_	_	
12-9	1566-1569	can	_	_	
12-10	1570-1575	cause	_	_	
12-11	1576-1587	significant	_	_	
12-12	1588-1601	complications	_	_	
12-13	1602-1611	including	_	_	
12-14	1612-1616	wire	_	_	
12-15	1617-1621	site	_	_	
12-16	1622-1631	infection	_	_	
12-17	1631-1632	,	_	_	
12-18	1633-1637	bone	_	_	
12-19	1638-1647	infection	_	_	
12-20	1647-1648	,	_	_	
12-21	1649-1653	pain	_	_	
12-22	1653-1654	,	_	_	
12-23	1655-1663	scarring	_	_	
12-24	1663-1664	,	_	_	
12-25	1665-1668	and	_	_	
12-26	1669-1679	restricted	_	_	
12-27	1680-1685	joint	_	_	
12-28	1686-1692	motion	_	_	
12-29	1693-1696	due	_	_	
12-30	1697-1699	to	_	_	
12-31	1700-1703	the	_	_	
12-32	1704-1717	transfixation	_	_	
12-33	1718-1720	of	_	_	
12-34	1721-1728	tendons	_	_	
12-35	1729-1732	and	_	_	
12-36	1733-1740	muscles	_	_	
12-37	1740-1741	.	_	_	

#Text=These complications are particularly relevant when the Ilizarov device is applied to the femur.
13-1	1742-1747	These	_	_	
13-2	1748-1761	complications	_	_	
13-3	1762-1765	are	_	_	
13-4	1766-1778	particularly	_	_	
13-5	1779-1787	relevant	_	_	
13-6	1788-1792	when	_	_	
13-7	1793-1796	the	_	_	
13-8	1797-1805	Ilizarov	_	_	
13-9	1806-1812	device	_	_	
13-10	1813-1815	is	_	_	
13-11	1816-1823	applied	_	_	
13-12	1824-1826	to	_	_	
13-13	1827-1830	the	_	_	
13-14	1831-1836	femur	_	_	
13-15	1836-1837	.	_	_	

#Text=In 1990, Brunner reported that distraction osteogenesis was achievable using intramedullary fixation in sheep tibiae.
14-1	1838-1840	In	_	_	
14-2	1841-1845	1990	_	_	
14-3	1845-1846	,	_	_	
14-4	1847-1854	Brunner	_	_	
14-5	1855-1863	reported	_	_	
14-6	1864-1868	that	_	_	
14-7	1869-1880	distraction	_	_	
14-8	1881-1893	osteogenesis	_	_	
14-9	1894-1897	was	_	_	
14-10	1898-1908	achievable	_	_	
14-11	1909-1914	using	_	_	
14-12	1915-1929	intramedullary	_	_	
14-13	1930-1938	fixation	_	_	
14-14	1939-1941	in	_	_	
14-15	1942-1947	sheep	_	_	
14-16	1948-1954	tibiae	_	_	
14-17	1954-1955	.	_	_	

#Text=Brunner's method still relied on the use of an external fixator to provide the force necessary for bone transport.
15-1	1956-1965	Brunner's	_	_	
15-2	1966-1972	method	_	_	
15-3	1973-1978	still	_	_	
15-4	1979-1985	relied	_	_	
15-5	1986-1988	on	_	_	
15-6	1989-1992	the	_	_	
15-7	1993-1996	use	_	_	
15-8	1997-1999	of	_	_	
15-9	2000-2002	an	_	_	
15-10	2003-2011	external	_	_	
15-11	2012-2019	fixator	_	_	
15-12	2020-2022	to	_	_	
15-13	2023-2030	provide	_	_	
15-14	2031-2034	the	_	_	
15-15	2035-2040	force	_	_	
15-16	2041-2050	necessary	_	_	
15-17	2051-2054	for	_	_	
15-18	2055-2059	bone	_	_	
15-19	2060-2069	transport	_	_	
15-20	2069-2070	.	_	_	

#Text=Brunner's work implied that transfixing wires used for internal fixation could potentially be eliminated.
16-1	2071-2080	Brunner's	_	_	
16-2	2081-2085	work	_	_	
16-3	2086-2093	implied	_	_	
16-4	2094-2098	that	_	_	
16-5	2099-2110	transfixing	_	_	
16-6	2111-2116	wires	_	_	
16-7	2117-2121	used	_	_	
16-8	2122-2125	for	_	_	
16-9	2126-2134	internal	_	_	
16-10	2135-2143	fixation	_	_	
16-11	2144-2149	could	_	_	
16-12	2150-2161	potentially	_	_	
16-13	2162-2164	be	_	_	
16-14	2165-2175	eliminated	_	_	
16-15	2175-2176	.	_	_	

#Text=Betz described the use of a telescoping intramedullary rod for distraction osteogenesis.
17-1	2177-2181	Betz	_	_	
17-2	2182-2191	described	_	_	
17-3	2192-2195	the	_	_	
17-4	2196-2199	use	_	_	
17-5	2200-2202	of	_	_	
17-6	2203-2204	a	_	_	
17-7	2205-2216	telescoping	_	_	
17-8	2217-2231	intramedullary	_	_	
17-9	2232-2235	rod	_	_	
17-10	2236-2239	for	_	_	
17-11	2240-2251	distraction	_	_	
17-12	2252-2264	osteogenesis	_	_	
17-13	2264-2265	.	_	_	

#Text=With the Betz device, the patient apparently turned a small knob that protruded from the patient's hip in order to telescopically move the parts relative to one another.
18-1	2266-2270	With	_	_	
18-2	2271-2274	the	_	_	
18-3	2275-2279	Betz	_	_	
18-4	2280-2286	device	_	_	
18-5	2286-2287	,	_	_	
18-6	2288-2291	the	_	_	
18-7	2292-2299	patient	_	_	
18-8	2300-2310	apparently	_	_	
18-9	2311-2317	turned	_	_	
18-10	2318-2319	a	_	_	
18-11	2320-2325	small	_	_	
18-12	2326-2330	knob	_	_	
18-13	2331-2335	that	_	_	
18-14	2336-2345	protruded	_	_	
18-15	2346-2350	from	_	_	
18-16	2351-2354	the	_	_	
18-17	2355-2364	patient's	_	_	
18-18	2365-2368	hip	_	_	
18-19	2369-2371	in	_	_	
18-20	2372-2377	order	_	_	
18-21	2378-2380	to	_	_	
18-22	2381-2395	telescopically	_	_	
18-23	2396-2400	move	_	_	
18-24	2401-2404	the	_	_	
18-25	2405-2410	parts	_	_	
18-26	2411-2419	relative	_	_	
18-27	2420-2422	to	_	_	
18-28	2423-2426	one	_	_	
18-29	2427-2434	another	_	_	
18-30	2434-2435	.	_	_	
